American National Insurance’s Vertex Pharmaceuticals VRTX Stock Holding History

American National Insurance’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$802K	Sell	3,075 -710	-19%	-$169K	0.22%	131
2021 Q4	$831K	Sell	3,785 -24,155	-86%	-$4.7M	0.18%	156
2021 Q3	$5.07M	Sell	27,940 -25	-0.1%	-$4.88K	0.19%	149
2021 Q2	$5.64M	Sell	27,965 -40	-0.1%	-$8.37K	0.21%	142
2021 Q1	$6.02M	Sell	28,005 -20	-0.1%	-$4.39K	0.25%	122
2020 Q4	$6.62M	Hold	28,025	–	–	0.28%	105
2020 Q3	$7.63M	Hold	28,025	–	–	0.37%	73
2020 Q2	$8.14M	Hold	28,025	–	–	0.42%	70
2020 Q1	$6.67M	Hold	28,025	–	–	0.43%	69
2019 Q4	$6.14M	Hold	28,025	–	–	0.32%	97
2019 Q3	$4.75M	Hold	28,025	–	–	0.25%	115
2019 Q2	$5.14M	Hold	28,025	–	–	0.27%	112
2019 Q1	$5.16M	Hold	28,025	–	–	0.27%	114
2018 Q4	$4.64M	Hold	28,025	–	–	0.27%	114
2018 Q3	$5.4M	Hold	28,025	–	–	0.27%	123
2018 Q2	$4.76M	Hold	28,025	–	–	0.24%	133
2018 Q1	$4.57M	Hold	28,025	–	–	0.23%	131
2017 Q4	$4.2M	Buy	+28,025	New	+$4.15M	0.21%	141

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

American National Insurance's VRTX Position: Q1 2022 in Review

American National Insurance reduced its Vertex Pharmaceuticals (VRTX) stake by 19% in Q1 2022, selling an estimated $169K and leaving 3,075 shares worth $802K. The position accounts for 0.22% of the portfolio, ranked #131.

American National Insurance first reported a position in VRTX in Q4 2017 and has held it in 18 quarters since. The position peaked at $8.14M in Q2 2020. 1,071 funds tracked by Wall St. Rank hold VRTX as of Q1 2022.

American National Insurance held 3,075 shares of Vertex Pharmaceuticals worth $802K as of Q1 2022.
American National Insurance sold 710 Vertex Pharmaceuticals shares in Q1 2022, an estimated $169K.
Vertex Pharmaceuticals made up 0.22% of American National Insurance's portfolio in Q1 2022, its #131 holding.
American National Insurance first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 18 quarters since.
American National Insurance's Vertex Pharmaceuticals position peaked at $8.14M in Q2 2020.
1,071 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2022.

Based on American National Insurance's 13F filing for Q1 2022, filed 13 May 2022.